References
- Glennås A, Rugstad H E. Acquired resistance to auranofin in cultured human cells. Scand J Rheumatol 1985; 14: 230–8
- Glennås A, Rugstad H E. Cultured human cells can acquire resistance to the antiproliferative effect of sodium aurothiomalate. Ann Rheum Dis 1986; 45: 389–95
- Glennås A, Hunziker P E, Garvey J S, Kägi J HR, Rugstad H E. Metallothionein in cultured human epithelial cells and synovial rheumatoid fibroblasts after in vitro treatment with auranofin. Biochem Pharmacol 1986; 35: 2033–40
- Blocka K LN, Paulus H E, Furst D E. Clinical pharmacokinetics of oral and injectable gold compounds. Clin Pharmacokinetics 1986; 11: 133–43
- Wessel J, Davis P. The effect of parenteral gold after auranofin failure in rheumatiod arthritis. J Rheumatol 1983; 10: 664
- Rainer F, Ulreich A. Vorlaufige Ergebnisse der oralen Goldmedikation mit Auranofin nach ungenügendem Erfolg der intramuskulären Goldtherapie. Wien Klin Wochenschr 1984; 10(Suppl.)49–51
- Ree K, Johnsen A S, Rugstad H E, Bakka A, Hovig T. Characterization of a human epithelial cell line with special reference to its ultrastructure. Acta Path Microbiol Scand, Sect A 1981; 89: 73–80
- Glennås A, Bakka A, Rugstad H E. Cultured human cells with a high content of metallothionein show resistance against gold-chloride. Scand J Rheumatol 1983; 12: 321–4
- Phillips H J. Dye exclusion test for cell viability. Tissue Culture, Methods and Applications, P F Kruse, M K Patterson. Academic Press, New York 1973; 406–8
- Snyder R M, Mirabelli C K, Crooke S T. Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions. Biochem Pharmacol 1986; 35: 923–32
- Snyder R M, Mirabelli C K, Crooke S T. The cellular pharmacology of auranofin. Semin Arthritis Rheum 1987; 17: 71–80
- Simon T M, Kunishima D H, Vibert G J, Lorber A. Inhibitory effect of a new oral gold compound on HeLa cells. Cancer 1979; 44: 1965–75
- Mirabelli C K, Crooke S T. Pharmacology of auranofin. A review and future perspective. Auranofin. Excerpta Medica, Current Clinical Practica Series, no. 7, H A Capell, D S Cole, K K Manghani, R W Morris. Elsevier Science Publishers BV, Amsterdam 1983
- Mirabelli C K, Johnson R K, Sung C M, Faucette L, Muirhead K. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auronofin, a coordinated gold compound, in murine tumor models. Cancer Res 1985; 45: 32–9
- Butt T R, Sternberg E J, Mirabelli C K, Crooke S T. Regulation of metallothionein gene expression in mammalian cells by gold compounds. Mol Pharmacol 1986; 29: 204–10
- Monia B P, Butt T R, Mirabelli C K, Ecker D J, Sternberg E, Crooke S T. Induction of metallothionein is correlated with resistance to auroanofin, a gold compound, in Chinese hamster ovary cells. Mol Pharmacol 1987; 31: 21–6